Why performance status? A case for alternative functional assessments in pediatric oncology clinical trials
Cancer
.
2021 Oct 1;127(19):3511-3513.
doi: 10.1002/cncr.33741.
Epub 2021 Jul 1.
Authors
Angela Steineck
1
2
,
Abby R Rosenberg
1
2
Affiliations
1
Cancer and Blood Disorders Center, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington.
2
Palliative Care and Resilience Lab, Center for Clinical and Translational Research, Seattle Children's Research Institute, Seattle, Washington.
PMID:
34196972
DOI:
10.1002/cncr.33741
No abstract available
Keywords:
PROs; clinical trials; patient-reported outcomes; pediatrics; performance status.
Publication types
Editorial
Research Support, N.I.H., Extramural
Comment
MeSH terms
Child
Humans
Medical Oncology*
Neoplasms* / therapy
Grants and funding
T32 HL125195/HL/NHLBI NIH HHS/United States
R01 CA225629/CA/NCI NIH HHS/United States
R01 CA222486/CA/NCI NIH HHS/United States